Novel digital marker detects minor hallucinations online at home of patients with Parkinson’s disease
Objective: The aim is to develop a novel implicit and quantitative marker for minor hallucinations (MH) in Parkinson’s disease (PD) for a better tracking of…Opicapone versus entacapone: Head-to-head comparison of Healthcare Resource Utilisation in COMT-I naïve People with Parkinson’s
Objective: In this retrospective cohort study, we assessed healthcare resource utilisation (HCRU) outcomes in People with Parkinson’s (PwP) naïve to Catechol-O-methyl transferase (COMT) inhibition via…Dysphagia in Parkinson’s disease
Objective: To evaluate the presence of dysphagia in patients with Parkinson Disease (PD) and determine associated factors and possible clinical predictors. Background: Parkinson's disease (PD)…Cerebellar ataxia as primary manifestation of HIV: a rare etiological association
Objective: We hereby report a case of subacute onset progressive pancerebellar ataxia, which after a thorough workup, turned out to be a primary manifestation of…Referral patterns from primary care physicians to specialists among people with Parkinson’s disease or a Parkinson’s disease–related disorder
Objective: To evaluate referral patterns to a specialist by a primary care provider (PCP) or other healthcare provider (HCP) among people diagnosed with Parkinson’s disease…MDS-UPDRS III Off Severity Level changes as a marker of DBS response
Objective: To determine the change in MDS-UPDRS III severity level after Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) in patients with Parkinson’s disease (PD) and evaluate…Contribution of MRI and machine learning approaches to the diagnosis of patients with early-stage parkinsonism in a situation of clinical uncertainty
Objective: To determine whether MRI and machine learning approaches improve diagnostic accuracy in patients with early-stage parkinsonism compared to clinical criteria Background: Parkinson’s disease (PD)…Path To Prevention (P2P) Therapeutics Platform Trial in Biomarker Defined Prodromal Parkinson’s Disease: Study Design
Objective: To describe the study design and proposed timeline of the first interventional study in biomarker defined prodromal Parkinson’s Disease (PD). Background: P2P is a…Substantia Nigra blood-brain barrier opening in Parkinson´s disease: PET (18F-Choline) evidence of parenchymal penetration
Objective: To evaluate clinical safety, feasibility, and tissue penetration (by 18F-Choline PET) of MR-guided focused ultrasound (MRgFUS) blood-brain barrier opening (BBB-O) of the substantia nigra…Levodopa-induced dyskinesia and Huntington’s chorea: link to current motor control theories
Objective: Determine if there is a motor control hypothesis that could explain movement kinematics of Huntington’s disease (HD) chorea and Parkinson’s disease (PD) levodopa-induced dyskinesia…
- « Previous Page
- 1
- …
- 197
- 198
- 199
- 200
- 201
- …
- 1554
- Next Page »